Serial testing with TB interferon-γ release assays: Toward a nuanced understanding

Chest

Volumn 142, Issue 6, 2012, Pages 1366-1368

  Pai, Madhukar ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

EDITORIAL; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; RISK BENEFIT ANALYSIS; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84870582321     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1208     Document Type: Editorial

References (15)

1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177-184.
2. Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011; 37(1):88-99.
3. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect. 2011;17(6):806-814.
4. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45-55.
5. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screen ing of healthcare workers: a systematic review. Thorax. 2012;67(1):62-70.
6. Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol. 2012;7(1):6.
7. Pai M, Elwood K. Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: Dynamic patterns and interpretational challenges. Can Respir J. 2012;19(2):81-83.
8. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Withinsubject variability of interferon-γ assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE. 2009;4(12): e8517.
9. Park JS, Lee JS, Kim MY, et al. Monthly follow-ups of interferon-γ release assays among health-care workers in contact with patients with TB. Chest. 2012;142(6):1461-1468.
10. Fong KS, Tomford JW, Teixeira L, et al. Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control program. Chest. 2012;142(1):55-62.
11. Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J. 2012;19(2):84-88.
12. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol. 2010;31(12):1279-1285.
13. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(11):181-185.
14. Public Health Agency of Canada. Tuberculosis in Canada 2010, Pre-Release. Ottawa, ON: Public Health Agency of Canada; 2010.
15. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005;353(10):1008-1020.